関連する実験動画
Updated: Sep 10, 2025
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
287
Idiopathic Pulmonary Fibrosis and Its Comorbidities: Gene Regulatory Mechanisms and Therapeutic Implications
Verónica Rocío Vásquez-Garzón1,2,3, Juan Manuel Velázquez-Enríquez1,4, Jovito Cesar Santos-Álvarez1
1Laboratorio de Fibrosis y Cáncer, Facultad de Medicina y Cirugía, Universidad Autónoma Benito Juárez de Oaxaca, Ex Hacienda de Aguilera S/N, Sur, San Felipe del Agua, Oaxaca C.P. 68020, Mexico.
Genes
|August 28, 2025
まとめ
クエルセチンは天然のフラボノイドで,イディオパシー性肺線維症 (IPF) および関連疾患の治療に有望である. 抗酸化と抗炎症効果は 重要な線維性経路と併発症を標的とし 新しい治療的可能性を秘めています
科学分野:
- 肺科
- 薬理学について
- 分子生物学
背景:
- Idiopathic pulmonary fibrosis (IPF) は進行する肺疾患で,治療の選択肢は限られている.
- 併発症はIPFの進行と患者のアウトカムに大きな影響を及ぼします.
- フラボノイドであるクエルセチンは 抗酸化,抗炎症,抗繊維性があります.
研究 の 目的:
- IPFにおけるクエルセチンの多面的な役割とその併発症をレビューする.
- 病気におけるクウェルセチンの 遺伝子調節メカニズムを強調するためです
- 治療策としてクエルセチンの可能性を探る
主な方法:
- IPFにおけるクエルセチンの臨床前および臨床試験のレビュー
- クエルセチンの分子経路 (Nrf2,SIRT1/AMPK,miRNAs) の調節に関する分析
- IPFに関連する併発症に対するクエルセチンの影響の検討
主要な成果:
- クエルセチンは,IPFの病原性に関与する主要な分子経路を調節する.
- クエルセチンは,COPD,心血管疾患,糖尿病などのIPF併発症に対する治療の可能性を示しています.
- クエルセチンはmiRNAsの表遺伝的調節と酸化ストレス/炎症の調節によって作用する.
結論:
- クエルセチンは,IPFの補助療法または代替療法として重要な可能性を秘めています.
- クエルセチンの有効性は,IPFに関連する併発症の管理に及ぶ.
- クエルセチンの遺伝子調節メカニズムに関するさらなる研究は,IPFの治療に必要である.
関連する概念動画
01:20COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:30Pulmonary Hypertension: Classification and Pathogenesis
284
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
284
01:28Gene Regulation in Microbial Communities: Quorum Sensing
92
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
92
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K